| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |